- €797.12m
- €743.62m
- €19.52m
French and Benelux stocks-Factors to watch on June 17
Brief: Medincell FY Total Revenue At Eur 24.3 Mln
France's MedinCell FY revenue drops on lower milestone income
Brief: Medincell Q1 2026 U.S. Net Sales Reached $63 Million
French and Benelux stocks-Factors to watch on March 27
Brief: Medincell Says EIB Waives Right To Cash Settlement Of Warrants
Brief: Medincell Completes EUR 48 Mln Private Placement
Brief: Medincell Launches A Private Placement For International Institutional Investors
Europe Research Roundup: CSG, Hochschild, Vestas
Brief: Medincell Says Uzedy Net Sales Increased 63% To $191 Million In 2025
Brief: Medincell H1 Revenues EUR 11.6 Mln
Brief: Medincell SA - Receives $3 Million Grant From Gates Foundation To Fight Malaria
Medincell at fresh record high FDA expands indication for schizophrenia treatment
Brief: MedinCell: FDA Approves Expanded Indication For Uzedy
French and Benelux stocks-Factors to watch
Brief: Teva And Medincell’S Risperidone Lai Approved In Canada As Longavo®
Teva Pharma rises after positive late-stage trial data for schizophrenia drug
Brief: Medincell Data Shows Uzedy Leads To Faster Discharge
Brief: Medincell Says Phase 3 Data Shows No PDSS In Olanzapine LAI